Cofoe Medical Technology Co.Ltd.
Cofoe Medical Technology Co.,Ltd. manufactures and sells professional household medical devices in China. It offers blood pressure monitors, nebulizers, thermometers, fingertip pulse oximeters, oxygen concentrators, fetal doppler, and CPAP and BPAP devices; in vitro diagnostic products, including glucose meters, HCG test kits, H.Pylori, UTM, DNA/RNA extraction reagents, and respiratory tract infe… Read more
Cofoe Medical Technology Co.Ltd. (301087) - Total Liabilities
Latest total liabilities as of June 2025: CN¥1.57 Billion CNY
Based on the latest financial reports, Cofoe Medical Technology Co.Ltd. (301087) has total liabilities worth CN¥1.57 Billion CNY as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Cofoe Medical Technology Co.Ltd. - Total Liabilities Trend (2019–2024)
This chart illustrates how Cofoe Medical Technology Co.Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Cofoe Medical Technology Co.Ltd. Competitors by Total Liabilities
The table below lists competitors of Cofoe Medical Technology Co.Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
DINE S.A.B. de C.V
MX:DINEB
|
Mexico | MX$4.38 Billion |
|
Transcat Inc
NASDAQ:TRNS
|
USA | $176.12 Million |
|
Guangxi Liuzhou Pharm Co Ltd
SHG:603368
|
China | CN¥13.05 Billion |
|
Motorcomm Electronic Technology Co. Ltd. A
SHG:688515
|
China | CN¥143.74 Million |
|
Kissei Pharmaceutical Co. Ltd
PINK:KSPHF
|
USA | $48.50 Billion |
Liability Composition Analysis (2019–2024)
This chart breaks down Cofoe Medical Technology Co.Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.65 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.33 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.25 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Cofoe Medical Technology Co.Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Cofoe Medical Technology Co.Ltd. (2019–2024)
The table below shows the annual total liabilities of Cofoe Medical Technology Co.Ltd. from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥1.62 Billion | +21.28% |
| 2023-12-31 | CN¥1.34 Billion | -3.04% |
| 2022-12-31 | CN¥1.38 Billion | +63.66% |
| 2021-12-31 | CN¥841.97 Million | -3.46% |
| 2020-12-31 | CN¥872.19 Million | +93.89% |
| 2019-12-31 | CN¥449.84 Million | -- |